Torrent Pharmaceuticals announced on Wednesday, 5 June, that the company has entered into a non-exclusive patent licensing agreement with Takeda for commercialising Vonoprazan in India. ...
Torrent Pharma, on 23 October, announced its quarterly report for the July-September quarter. The Pharma company reported a 23.7% year-on-year (YoY) growth in its net...
On the Bombay Stock Exchange (BSE), Torrent Pharmaceuticals Ltd recorded a volume of 87,800 shares, over the two-week average daily volume of 3,784 shares JM...